ATE256656T1 - Adamantancarboximidamid-derivate und ihre anwendung als nmda-antagonisten - Google Patents
Adamantancarboximidamid-derivate und ihre anwendung als nmda-antagonistenInfo
- Publication number
- ATE256656T1 ATE256656T1 AT99902711T AT99902711T ATE256656T1 AT E256656 T1 ATE256656 T1 AT E256656T1 AT 99902711 T AT99902711 T AT 99902711T AT 99902711 T AT99902711 T AT 99902711T AT E256656 T1 ATE256656 T1 AT E256656T1
- Authority
- AT
- Austria
- Prior art keywords
- adamantancarboximidamide
- derivatives
- nmda antagonists
- glutamtergic
- prodrugs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/16—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9802225.4A GB9802225D0 (en) | 1998-02-02 | 1998-02-02 | Chemical compounds |
PCT/GB1999/000321 WO1999038841A1 (en) | 1998-02-02 | 1999-02-01 | Adamantanecarboximidamide derivatives and their use as nmda antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE256656T1 true ATE256656T1 (de) | 2004-01-15 |
Family
ID=10826332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99902711T ATE256656T1 (de) | 1998-02-02 | 1999-02-01 | Adamantancarboximidamid-derivate und ihre anwendung als nmda-antagonisten |
Country Status (8)
Country | Link |
---|---|
US (1) | US6262106B1 (de) |
EP (1) | EP1051392B1 (de) |
JP (1) | JP2002501942A (de) |
AT (1) | ATE256656T1 (de) |
AU (1) | AU2292199A (de) |
DE (1) | DE69913652D1 (de) |
GB (1) | GB9802225D0 (de) |
WO (1) | WO1999038841A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1100504A2 (de) | 1998-07-02 | 2001-05-23 | Eisai Co., Ltd. | Pharmazeutische zubereitungen und verwendung zur behandlung demyelinisierender erkrankungen |
GB9901691D0 (en) | 1999-01-26 | 1999-03-17 | Cerebrus Ltd | Chemical compounds |
GB0018272D0 (en) * | 2000-07-25 | 2000-09-13 | Vernalis Research Limited | Chemical compounds IV |
GB0202161D0 (en) * | 2002-01-30 | 2002-03-20 | Vernalis Res Ltd | Chemical compounds V |
TW200403066A (en) * | 2002-04-30 | 2004-03-01 | Novartis Ag | New uses of substituted aminoalkanephosphonic acids |
MXPA05012493A (es) * | 2003-05-27 | 2006-05-25 | Forest Laboratories | Combinacion de un antagonista del receptor de nmda y un inhibidor selectivo de reabsorcion de serotonina para el tratamiento de depresion y otros trastornos de estado de animo. |
ITTO20030668A1 (it) * | 2003-09-02 | 2005-03-03 | Rotta Res Lab S P A O Ra Rottapharm | Derivati dell'adamantano dotati di attivita' neuroprotettiva, antidepressiva e anti-ischemica e procedimento per la loro preparazione. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3829581A (en) | 1970-07-23 | 1974-08-13 | Du Pont | Aliphatic polycyclic amidoximes as influenza antiviral agents |
DE58905637D1 (de) | 1989-04-14 | 1993-10-21 | Merz & Co Gmbh & Co | Verwendung von Adamantan-Derivaten zur Prävention und Behandlung der cerebralen Ischämie. |
-
1998
- 1998-02-02 GB GBGB9802225.4A patent/GB9802225D0/en not_active Ceased
-
1999
- 1999-01-01 US US09/600,168 patent/US6262106B1/en not_active Expired - Fee Related
- 1999-02-01 AU AU22921/99A patent/AU2292199A/en not_active Abandoned
- 1999-02-01 DE DE69913652T patent/DE69913652D1/de not_active Expired - Lifetime
- 1999-02-01 WO PCT/GB1999/000321 patent/WO1999038841A1/en active IP Right Grant
- 1999-02-01 EP EP99902711A patent/EP1051392B1/de not_active Expired - Lifetime
- 1999-02-01 JP JP2000530079A patent/JP2002501942A/ja not_active Withdrawn
- 1999-02-01 AT AT99902711T patent/ATE256656T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1051392B1 (de) | 2003-12-17 |
WO1999038841A1 (en) | 1999-08-05 |
JP2002501942A (ja) | 2002-01-22 |
WO1999038841A8 (en) | 2000-10-12 |
US6262106B1 (en) | 2001-07-17 |
DE69913652D1 (de) | 2004-01-29 |
EP1051392A1 (de) | 2000-11-15 |
AU2292199A (en) | 1999-08-16 |
GB9802225D0 (en) | 1998-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0018272D0 (en) | Chemical compounds IV | |
DE69923849D1 (de) | Quinolin-2-on-derivate verwendbar als antikrebsmittel | |
TR200000129T2 (tr) | Yepyeni spiroazabisiklik heterosiklik bileşikler. | |
HK1069395A1 (en) | Phthalazinone derivatives 2,3 | |
SE9903998D0 (sv) | New compounds | |
TW200502230A (en) | Dual nk1/nk3 derivatives | |
AU2002249890A1 (en) | Carboline derivatives | |
BRPI0409959A (pt) | uso de derivados de azetidinacarboxamida em terapia | |
SE9903997D0 (sv) | New compounds | |
ATE256656T1 (de) | Adamantancarboximidamid-derivate und ihre anwendung als nmda-antagonisten | |
MXPA03003971A (es) | Derivados de indol como inhibidores de pde5. | |
AU2116900A (en) | 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission | |
ATE330958T1 (de) | Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate | |
MXPA05006957A (es) | Nuevos derivados de fosforamida. | |
HRP20010885B1 (en) | Ethanesulfonyl-piperidine derivatives | |
ES2185237T3 (es) | 1-(asamantil)amidinas y su utilizacion en el tratamiento de estados generalmente asociados con anomalias en la transmision glutamatergica. | |
GEP20063758B (en) | Benzothia(Dia)Zine Derivatives and Method for Their Use as AMPA Modulators | |
ES2159489A1 (es) | Nuevos derivados de imidazol con actividad antiinflamatoria. | |
SE9903996D0 (sv) | New compounds | |
DE60027204D1 (en) | Benzamidinderivate | |
AU2406700A (en) | 3,4-dihydro-2h-benzo(1,4)oxazinyl-methyl(3-(1h-indol-3-yl)-a kyl)-amines | |
AU2178199A (en) | Azetidinecarboxamide derivatives for the treatment of cns disorders | |
AU2178099A (en) | Azetidinecarboxamide derivatives for treating cns disorders | |
PL356931A1 (en) | Use of natural compounds having antiangiogenic activity | |
MX9704976A (es) | Derivados de 1,2,3-benzotiadiazol. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |